title: Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Ida
authors.initials: I
authors.lastname: Carmosino
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Daniela
authors.initials: D
authors.lastname: Diverio
authors.forename: Anna
authors.initials: A
authors.lastname: Guarini
authors.forename: Maria Stefania
authors.initials: MS
authors.lastname: De Propris
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Petti
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Avvisati
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cimino
authors.forename: Franco
authors.initials: F
authors.lastname: Mandelli
authors.forename: Francesco
authors.initials: F
authors.lastname: Lo-Coco
mesh_terms: D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy*; D013577:Syndrome; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D014212:Tretinoin; D015255:Idarubicin